Clinical Trial Update: Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update indicates that Holmium-166 transarterial radioembolization for hepatocellular carcinoma is currently recruiting, with locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• QuiremSpheres (Holmium-166 microspheres)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Locally Advanced Hepatocellular Carcinoma, Liver Cirrhosis | Status: RECRUITING